Arterial stiffness and cardiovascular risk in hypertension

P Boutouyrie, P Chowienczyk, JD Humphrey… - Circulation …, 2021 - Am Heart Assoc
Arterial stiffness, a leading marker of risk in hypertension, can be measured at material or
structural levels, with the latter combining effects of the geometry and composition of the …

Chronic kidney disease in children

F Becherucci, RM Roperto, M Materassi… - Clinical kidney …, 2016 - academic.oup.com
Chronic kidney disease (CKD) is a major health problem worldwide. Although relatively
uncommon in children, it can be a devastating illness with many long-term consequences …

Vascular calcification in CKD-MBD: Roles for phosphate, FGF23, and Klotho

S Yamada, CM Giachelli - Bone, 2017 - Elsevier
Vascular calcification (VC) is highly prevalent in aging, diabetes mellitus, and chronic kidney
disease (CKD). VC is a strong predictor of cardiovascular morbidity and mortality in the CKD …

Peripheral arterial calcification: prevalence, mechanism, detection, and clinical implications

KJ Rocha‐Singh, T Zeller… - Catheterization and …, 2014 - Wiley Online Library
Vascular calcification (VC), particularly medial (Mönckeberg's medial sclerosis) arterial
calcification, is common in patients with diabetes mellitus and chronic kidney disease and is …

Enhanced cytocompatibility and antibacterial property of zinc phosphate coating on biodegradable zinc materials

Y Su, K Wang, J Gao, Y Yang, YX Qin, Y Zheng, D Zhu - Acta biomaterialia, 2019 - Elsevier
Zinc (Zn) has recently emerged as a promising biodegradable metal thanks to its critical
physiological roles and promising degradation behavior. However, cytocompatibility and …

Effect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta …

SA Jamal, B Vandermeer, P Raggi, DC Mendelssohn… - The Lancet, 2013 - thelancet.com
Background Phosphate binders (calcium-based and calcium-free) are recommended to
lower serum phosphate and prevent hyperphosphataemia in patients with chronic kidney …

The ADVANCE study: a randomized study to evaluate the effects of cinacalcet plus low-dose vitamin D on vascular calcification in patients on hemodialysis

P Raggi, GM Chertow, PU Torres… - Nephrology Dialysis …, 2011 - academic.oup.com
Background. This prospective, randomized, controlled trial compared the progression of
vascular and cardiac valve calcification in 360 prevalent adult hemodialysis patients with …

[PDF][PDF] Clinical practice guideline for the management of chronic kidney disease‐mineral and bone disorder

M Fukagawa, K Yokoyama, F Koiwa… - … Apheresis and Dialysis, 2013 - jsdt.or.jp
Masafumi Fukagawa, 1 Keitaro Yokoyama, 1 Fumihiko Koiwa, 1 Masatomo Taniguchi, 1
Tetsuo Shoji, 1 Junichiro James Kazama, 1 Hirotaka Komaba, 1 Ryoichi Ando, 1 Takatoshi …

Mechanistic insights into vascular calcification in CKD

R Shroff, DA Long, C Shanahan - Journal of the American Society …, 2013 - journals.lww.com
Cardiovascular disease begins early in the course of renal decline and is a life-limiting
problem in patients with CKD. The increased burden of cardiovascular disease is due, at …

CKD, arterial calcification, atherosclerosis and bone health: Inter-relationships and controversies

AB Reiss, N Miyawaki, J Moon, LJ Kasselman… - Atherosclerosis, 2018 - Elsevier
Mineral bone disease (MBD) is a common complication of chronic kidney disease (CKD)
characterized by disruption of normal mineral homeostasis within the body. One or more of …